Increasing Natural Killer Cell Activity with ImmPower-AHCC is the Key, as published in Journal of Nutrition

Philadelphia, PA - Researchers at Drexel University’s Department of Bioscience & Biotechnology successfully demonstrated an increased immune response to influenza infection in subjects given the all natural supplement ImmPower™, which contains pure AHCC (Active Hexose Correlated Compound), a hybridized mushroom extract. This original research, conducted by immunologists Dr. Elizabeth Gardner, Barry Ritz & colleagues, appears in Journal of Nutrition, November, 2006. The supplement, distributed by NY-based American BioSciences, Inc., appears to boost the immune response to influenza, in particular, a vital part of the immune system called Natural Killer (NK) cells. This finding is of critical importance because an immediate immune response from NK Cells is responsible for lessening both the duration and the severity of the influenza infection.

Though more than 32 studies have already been published, Drexel’s is the first to evaluate ImmPower’s AHCC in the context of influenza, demonstrating its efficacy in protecting against the flu’s consequences: * reducing the rate of infection, * reducing the severity of infection, both in terms of symptoms and damage to lungs, * speeding the rate of recovery and reducing the duration of illness, and * dramatically reducing the fatal consequences.

American BioSciences, the first to introduce ImmPower-AHCC into the US more than 7 years ago & still its largest distributor, worked closely with Drexel in helping design this study. With the current increase in the threat of influenza viruses, studies showing the decrease in protection from flu shots, and the recent controversy about anti-flu drugs, Drexel’s good news about ImmPower-AHCC couldn’t come at a better time.

Drexel’s Study Shows Increasing Natural Killer Cells with ImmPower-AHCC Helps Fight the Flu
NK Cells are the immune system’s first line of defense against virus, hunting the germs down before they have the ability to spread & affect overall health. NK Cell response is ultimately responsible for stopping the progression of influenza infection and helping to clear the infection. In this study, ImmPower’s AHCC appears to increase NK Cell activity immediately, and help achieve peak NK Cell activity within 48 hours.

For more on the study & ImmPower-AHCC: 1-888-884-7770, www.AHCCflu.info, www.americanbiosciences.com and for interviewing Barry Ritz, lead author of this study, contact the Press Contact, Linda Bryer, 831-479-8725, [email protected]